Results 101 to 110 of about 11,630 (189)

End‐to‐end deep learning pipeline for automated IMRT planning in lymphoma: Feasibility and limitations

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background Intensity‐modulated radiation therapy (IMRT) is widely used for lymphoma because a multileaf collimator (MLC) can sculpt dose around irregular targets. Planning, however, is time‐consuming and difficult to standardize. Fluence map prediction (FMP) using deep learning (DL) could potentially be used to automate planning, but it has ...
Denis Kutnár   +5 more
wiley   +1 more source

A Comprehensive Review of Tire Abrasion: Mechanisms, Parameters, and Wear Rates in the Era of Vehicle Electrification

open access: yesApplied Research, Volume 5, Issue 4, August 2026.
The type of vehicle (internal combustion, hybrid, electric) has a direct effect on its tire wear particle emission. As expected, electric vehicles generate higher amounts due to their higher weight and torque, but regenerative breaking must also be accounted for.
Xiao Yuan Chen, Denis Rodrigue
wiley   +1 more source

Beyond the grave: Do the dead have rights?

open access: yesAnatomical Sciences Education, Volume 19, Issue 8, Page 1360-1366, August 2026.
Abstract Anatomists who work with the Dead often see themselves as custodians of the Dead. To those who opine that the Dead no longer have Rights (legal or moral) or privileges and have nothing more to contribute to the development of Society or to human endeavor, the Dead's custodians might respond that there is ample evidence that some Rights and ...
Beverley Kramer, Bernard Moxham
wiley   +1 more source

Low‐Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer

open access: yesCancer Innovation, Volume 5, Issue 4, August 2026.
Antiangiogenic‐based regimens demonstrated superior efficacy compared to chemotherapy alone in heavily pretreated MBC patients, with manageable AEs. ABSTRACT Background The prognosis for metastatic breast cancer (MBC) remains poor, and treatment options are limited for patients with heavily pretreated disease. Although antiangiogenic agents may provide
Yuanyi Wang   +6 more
wiley   +1 more source

Prognostic Impact of PD‐L1 Expression in Ovarian Cancer: Analysis of a Real‐World Cohort Treated With Primary Platinum‐Based Chemotherapy

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Programmed death‐ligand 1 (PD‐L1) has emerged as a potential biomarker for prognosis and treatment response in various solid tumors. However, its clinical relevance in ovarian carcinoma (OC) remains unclear, with published studies reporting inconsistent associations with platinum sensitivity and survival.
Jitka Hausnerova   +10 more
wiley   +1 more source

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma

open access: yesCancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Glioblastoma (GB) is the most aggressive primary malignant brain tumor in adults and remains associated with poor survival despite surgical resection followed by radiotherapy and temozolomide (TMZ) chemotherapy. Intrinsic and acquired resistance to TMZ, including MGMT‐dependent DNA repair and activation of pro‐survival pathways ...
Ali Nakhaei   +5 more
wiley   +1 more source

Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study

open access: yesCancer Management and Research
Xuexue Bai,1 Hao Xing,1 Ming Feng,1 Wenbin Ma,1 Shiyong Wang2 1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China; 2Department of ...
Bai X, Xing H, Feng M, Ma W, Wang S
doaj  

Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy. [PDF]

open access: yesAsian J Pharm Sci
Zhu X   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy